BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33335254)

  • 1. Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach.
    Qi Y; Lai YL; Shen PC; Chen FH; Lin LJ; Wu HH; Peng PH; Hsu KW; Cheng WC
    Sci Rep; 2020 Dec; 10(1):22270. PubMed ID: 33335254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A microRNA-Messenger RNA Regulatory Network and Its Prognostic Value in Cervical Cancer.
    Liu J; Yang J; Gao F; Li S; Nie S; Meng H; Sun R; Wan Y; Jiang Y; Ma X; Cheng W
    DNA Cell Biol; 2020 Jul; 39(7):1328-1346. PubMed ID: 32456463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
    Zeng Y; Wang KX; Xu H; Hong Y
    J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A three miRNAs signature predicts survival in cervical cancer using bioinformatics analysis.
    Liang B; Li Y; Wang T
    Sci Rep; 2017 Jul; 7(1):5624. PubMed ID: 28717180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal subset of signature miRNAs consisting of 7 miRNAs that can serve as a novel diagnostic and prognostic predictor for the progression of cervical cancer.
    Shi C; Yang Y; Zhang L; Zhang T; Yu J; Qin S; Gao Y
    Oncol Rep; 2019 Jun; 41(6):3167-3178. PubMed ID: 30942460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
    Liu H; Liu L; Zhu H
    J Comput Biol; 2019 Apr; 26(4):387-395. PubMed ID: 30762435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
    Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
    Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.
    He S; Liao B; Deng Y; Su C; Tuo J; Liu J; Yao S; Xu L
    BMC Cancer; 2017 Oct; 17(1):673. PubMed ID: 28978307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
    Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
    Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
    Zhao X; Cui L
    J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix.
    Lee H; Kim KR; Cho NH; Hong SR; Jeong H; Kwon SY; Park KH; An HJ; Kim TH; Kim I; Yoon HK; Suh KS; Min KO; Choi HJ; Park JY; Yoo CW; Lee YS; Lee HJ; Lee WS; Park CS; Lee Y;
    World J Surg Oncol; 2014 Nov; 12():334. PubMed ID: 25381598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of miRNA-mRNA Regulatory Network and Construction of Prognostic Signature in Cervical Cancer.
    Mei Y; Jiang P; Shen N; Fu S; Zhang J
    DNA Cell Biol; 2020 Jun; 39(6):1023-1040. PubMed ID: 32349536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A microRNA expression signature for cervical cancer prognosis.
    Hu X; Schwarz JK; Lewis JS; Huettner PC; Rader JS; Deasy JO; Grigsby PW; Wang X
    Cancer Res; 2010 Feb; 70(4):1441-8. PubMed ID: 20124485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-374c-5p regulates the invasion and migration of cervical cancer by acting on the Foxc1/snail pathway.
    Huang Y; Huang H; Li M; Zhang X; Liu Y; Wang Y
    Biomed Pharmacother; 2017 Oct; 94():1038-1047. PubMed ID: 28810526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers.
    Gao C; Zhou C; Zhuang J; Liu L; Liu C; Li H; Liu G; Wei J; Sun C
    J Cell Biochem; 2018 Aug; 119(8):7080-7090. PubMed ID: 29737570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance.
    Li C; Yin Y; Liu X; Xi X; Xue W; Qu Y
    Oncotarget; 2017 Apr; 8(15):24564-24578. PubMed ID: 28445945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.